Niagen Bioscience, Inc. (NAGE) Return On Equity

Annual ROE:

22.94%+40.23%(+232.68%)
December 31, 2024

Summary

  • As of today, NAGE annual return on equity is 22.94%, with the most recent change of +40.23% (+232.68%) on December 31, 2024.
  • During the last 3 years, NAGE annual ROE has risen by +135.62% (+120.36%).
  • NAGE annual ROE is now at all-time high.

Performance

NAGE ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEprofitability metrics

Quarterly ROE:

37.74%-0.68%(-1.77%)
September 30, 2025

Summary

  • As of today, NAGE quarterly return on equity is 37.74%, with the most recent change of -0.68% (-1.77%) on September 30, 2025.
  • Over the past year, NAGE quarterly ROE has increased by +32.78% (+660.89%).
  • NAGE quarterly ROE is now -1.77% below its all-time high of 38.42%, reached on June 30, 2025.

Performance

NAGE Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

NAGE ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+232.7%+660.9%
3Y3 Years+120.4%+149.8%
5Y5 Years+117.0%+135.0%

NAGE ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+120.4%-1.8%+149.8%
5Y5-Yearat high+117.0%-1.8%+135.0%
All-TimeAll-Timeat high+106.5%-1.8%+105.6%

NAGE ROE History

DateAnnualQuarterly
Sep 2025
-
37.74%(-1.8%)
Jun 2025
-
38.42%(+6.5%)
Mar 2025
-
36.08%(+42.3%)
Dec 2024
22.94%(+232.7%)
25.36%(+411.3%)
Sep 2024
-
4.96%(+204.6%)
Jun 2024
-
-4.74%(+62.4%)
Mar 2024
-
-12.61%(+28.7%)
Dec 2023
-17.29%(+68.4%)
-
Dec 2023
-
-17.69%(+27.7%)
Sep 2023
-
-24.48%(+5.3%)
Jun 2023
-
-25.85%(+39.9%)
Mar 2023
-
-43.03%(+33.4%)
Dec 2022
-54.77%(+51.4%)
-64.57%(+14.8%)
Sep 2022
-
-75.81%(+16.5%)
Jun 2022
-
-90.78%(-18.2%)
Mar 2022
-
-76.77%(+4.0%)
Dec 2021
-112.68%(-4.2%)
-79.99%(+9.8%)
Sep 2021
-
-88.66%(-9.4%)
Jun 2021
-
-81.06%(+10.7%)
Mar 2021
-
-90.79%(+13.9%)
Dec 2020
-108.09%(+19.9%)
-105.44%(+2.2%)
Sep 2020
-
-107.80%(+15.3%)
Jun 2020
-
-127.24%(+14.1%)
Mar 2020
-
-148.18%(-2.2%)
Dec 2019
-135.01%(-64.1%)
-144.95%(-13.9%)
Sep 2019
-
-127.22%(-6.1%)
Jun 2019
-
-119.95%(-21.9%)
Mar 2019
-
-98.42%(-19.1%)
Dec 2018
-82.25%(-58.8%)
-82.64%(-1.4%)
Sep 2018
-
-81.48%(-14.5%)
Jun 2018
-
-71.18%(-4.0%)
Mar 2018
-
-68.42%(-9.8%)
Dec 2017
-51.81%(-11.2%)
-62.31%(-14.2%)
Sep 2017
-
-54.57%(+0.4%)
Jun 2017
-
-54.78%(-9.8%)
Mar 2017
-
-49.89%(-56.1%)
Dec 2016
-46.58%
-31.97%(-18.3%)
Sep 2016
-
-27.02%(-39.2%)
DateAnnualQuarterly
Jun 2016
-
-19.41%(+38.4%)
Mar 2016
-
-31.53%(+51.8%)
Dec 2015
-59.77%(+46.4%)
-65.37%(-3.8%)
Sep 2015
-
-62.96%(+20.4%)
Jun 2015
-
-79.09%(+26.2%)
Mar 2015
-
-107.16%(+7.4%)
Dec 2014
-111.51%(-21.9%)
-115.72%(-6.8%)
Sep 2014
-
-108.31%(+0.1%)
Jun 2014
-
-108.47%(-24.7%)
Mar 2014
-
-87.00%(-212.4%)
Dec 2013
-91.51%(+74.3%)
-27.85%(+40.4%)
Sep 2013
-
-46.75%(+2.5%)
Jun 2013
-
-47.96%(+50.4%)
Mar 2013
-
-96.60%(+57.5%)
Dec 2012
-355.85%(-69.0%)
-227.31%(+4.3%)
Sep 2012
-
-237.58%(+9.2%)
Jun 2012
-
-261.61%(-16.5%)
Mar 2012
-
-224.54%(-22.5%)
Dec 2011
-210.60%(-207.1%)
-183.23%(-40.2%)
Sep 2011
-
-130.69%(-37.4%)
Jun 2011
-
-95.10%(-27.9%)
Mar 2011
-
-74.38%(-29.2%)
Dec 2010
-68.58%(-5.7%)
-57.56%(-27.1%)
Sep 2010
-
-45.30%(-62.7%)
Jun 2010
-
-27.84%(+39.3%)
Mar 2010
-
-45.87%(+33.2%)
Dec 2009
-64.91%(+73.0%)
-68.63%(+30.5%)
Sep 2009
-
-98.72%(+16.9%)
Jun 2009
-
-118.81%(+25.7%)
Mar 2009
-
-159.97%(+7.1%)
Dec 2008
-240.60%(-21.6%)
-172.26%(-12.3%)
Sep 2008
-
-153.39%(+1.8%)
Jun 2008
-
-156.24%(+53.8%)
Feb 2008
-
-338.31%(+49.7%)
Nov 2007
-197.94%(-5352.9%)
-671.93%(-45.5%)
Aug 2007
-
-461.95%(-43.1%)
May 2007
-
-322.75%(-27.5%)
Feb 2007
-
-253.21%
Nov 2006
-3.63%
-

FAQ

  • What is Niagen Bioscience, Inc. annual return on equity?
  • What is the all-time high annual ROE for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual ROE year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly ROE year-on-year change?

What is Niagen Bioscience, Inc. annual return on equity?

The current annual ROE of NAGE is 22.94%

What is the all-time high annual ROE for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual return on equity is 22.94%

What is Niagen Bioscience, Inc. annual ROE year-on-year change?

Over the past year, NAGE annual return on equity has changed by +40.23% (+232.68%)

What is Niagen Bioscience, Inc. quarterly return on equity?

The current quarterly ROE of NAGE is 37.74%

What is the all-time high quarterly ROE for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly return on equity is 38.42%

What is Niagen Bioscience, Inc. quarterly ROE year-on-year change?

Over the past year, NAGE quarterly return on equity has changed by +32.78% (+660.89%)
On this page